Advances in Brief Suppression of a Squamous Cell Carcinoma ( SCC )-related Serpin , SCC Antigen , Inhibits Tumor Growth with Increased Intratumor Infiltration of Natural Killer Cells 1

Squamous cell carcinoma (SCC) antigen (SCCA), a member of the ovalbumin serine proteinase inhibitor family, serves as a circulating marker of squamous cell carcinoma (SC). One of the SCCAs, SCCA1, has been suggested to play a role in the attenuation of apoptosis in vitro and in the augmentation of tumor growth in vivo. In the present study, the infection of a SCC cell line (SKG IIIa) with recombinant retrovirus that expressed the antisense SCCAmRNA suppressed expression of SCCAin vitro. Local administration of this retrovirus into tumors by inoculation in nude mice suppressed tumor growth. Treatment of tumor tissuein vivo is also associated with increased numbers of apoptotic tumor cells and large mononuclear cells in the tumor. To test the possible role of SCCA in the infiltration of large mononuclear cells, we analyzed the effect of SCCA1 on migration of natural killer (NK) cells induced by monocyte-chemoattractant protein-1 in vitro. SCCA1 suppressed migration of NK cells completely, and this inhibitory effect was lost by mutation of the reactive site loop of SCCA1. These results suggest that antisense SCCA may suppress the growth of SCC in vivo not only by the augmentation of intracellular apoptosis but also by the increased infiltration of NK cells into the tumor.

[1]  F. Kishi,et al.  Specific Detection and Quantitation of SCC Antigen 1 and SCC Antigen 2 mRNAs by Fluorescence-Based Asymmetric Semi-Nested Reverse Transcription PCR , 2000, Tumor Biology.

[2]  T. Whiteside,et al.  Inhibition of apoptosis in human tumour cells by the tumour-associated serpin, SCC antigen-1 , 2000, British Journal of Cancer.

[3]  F. Numa,et al.  Identification of squamous cell carcinoma antigen‐2 in tumor tissue by two‐dimensional electrophoresis , 1999, Electrophoresis.

[4]  D. Brömme,et al.  The reactive site loop of the serpin SCCA1 is essential for cysteine proteinase inhibition. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Y. Suminami,et al.  In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2. , 1997, Cancer gene therapy.

[6]  G. Silverman,et al.  Squamous Cell Carcinoma Antigen 2 Is a Novel Serpin That Inhibits the Chymotrypsin-like Proteinases Cathepsin G and Mast Cell Chymase* , 1997, The Journal of Biological Chemistry.

[7]  N. Katunuma,et al.  Electrophoretic analysis of the “cross‐class” interaction between novel inhibitory serpin, squamous cell carcinoma antigen‐1 and cysteine proteinases , 1997, Electrophoresis.

[8]  L. McDonald,et al.  A Cytosolic Granzyme B Inhibitor Related to the Viral Apoptotic Regulator Cytokine Response Modifier A Is Present in Cytotoxic Lymphocytes* , 1996, The Journal of Biological Chemistry.

[9]  T. Whiteside,et al.  Nonsecretory apoptotic killing by human NK cells. , 1996, Journal of immunology.

[10]  縄田 修吾 Serine protease inhibitor activity of recombinant squamous cell carcinoma antigen towards chymotrypsin, as demonstrated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis , 1996 .

[11]  J. Dickinson,et al.  Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor alpha-induced apoptosis. Evidence for an alternate biological function. , 1995, The Journal of biological chemistry.

[12]  W. Telford,et al.  CrmA, a Poxvirus-encoded Serpin, Inhibits Cytotoxic T-lymphocyte-mediated Apoptosis (*) , 1995, The Journal of Biological Chemistry.

[13]  G. Silverman,et al.  A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[14]  F. Kishi,et al.  Squamous cell carcinoma antigen is a new member of the serine protease inhibitors. , 1991, Biochemical and biophysical research communications.

[15]  H. Tamura,et al.  Different behaviors in the production and release of SCC antigen in squamous-cell carcinoma. , 1991, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[16]  A. Iio,et al.  Availability of tumor‐antigen 4 as a marker of squamous cell carcinoma of the lung and other organs , 1988, Cancer.

[17]  H. Kato,et al.  Heterogeneity of a tumor antigen TA-4 of squamous cell carcinoma in relation to its appearance in the circulation. , 1984, Gan.

[18]  H. Kato,et al.  Radioimmunoassay for tumor-antigen of human cervical squamous cell carcinoma. , 1977, Cellular and molecular biology, including cyto-enzymology.